In 2011, the team at Fore, originally Novellus, began with a sole algorithm designed to identify rare cancer-driving mutations. As the company grew, they expanded the technology into a novel genomics platform that could match innovative therapies to patients with previously untreatable cancers. With this transformation, the biotech needed an identity to support its growth and communicate the impact of its discovery.
Team created a ground-up rebrand, including a new name, tonality & messaging, visual identity, and website, that centered on the company’s unique balance between its tech-driven approach and deep focus on human connection.
The new name establishes the firm as a true next-generation company, ready to lead the way into uncharted territory. Team further defined the brand’s commitment to predictive therapeutics with the naming of their proprietary platform, Foresight.
A bespoke logo emblem of dots and lines merges the binary language of their machine-learning engine with the human element of DNA. An approachable sans-serif type and a humanistic color palette offer a welcomed break from a traditional clinical field and affirm Fore’s patient-centric mission. To reach a diverse global audience, Fore’s new website features compelling 3D renderings to present its programs, publications, and the science behind their groundbreaking discoveries.
Fore’s new identity positions the company as a global player in the precision oncology arena and a true leader signaling new pathways to finding a cure.